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storage proﬁle in 329 in 2004, 215 families in 2006, living in
central Ankara and compare drug usage behaviour between 2
years. The questionnaire had two parts, the ﬁrst included the
demographic properties of the families. The second part included
for any drug found in their house, the size of the package, the
unused amount of the drug and expiry date of drugs. RESULTS:
About 90% of the families receive drugs from social security
agencies in 2004, 99% in 2006. The mostly found three drugs
were Aspirin® (acetyl salicilic acid), Vermidon® (paracetamole),
and Mesulide® (nimesulide) in 2004, And Vermidon® (parac-
etamole), Aspirin® (acetyl salicilic acid), Majezik® (Flurbipro-
fen) in 2006. When ingredients were analyized, the three, mostly
found, active compounds were paracetamole, multivitamin
preparates, and acetyl salisilic acid in 2004, and paracetamole,
acetyl salisilic acid, multivitamin preparates in 2006. The drugs
with the largest amount of packaging were found to be the most
wasted. In 2006, 53% of drugs were completely or partially
unused. Thirty-one percent of them were completely unused.
Among the drugs wasted some antibiotics such as sultamicillin
and co-amoxilav were higher rate. CONCLUSION: This survey
shows that there is a great deal of drug waste (product and $),
in Turkey. We estimated that Turkish Social Security Agencies
are wasting more than 1 billion US $ just for never used drugs
and another 1 billion US $ for partially used drugs (Turkish drug
market is about 7 billion US $). Drug expenditure is, by far, the
highest proportion of the Turkish health costs expenditure
(about 60% total health cost expendature), and it creates a heavy
ﬁnancial burden on the Turkish government.
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OBJECTIVES: Few studies examine the effects of higher pre-
scription drug cost-sharing on children, although they are subject
to the same cost-sharing provisions as adults. Children also are
dependent upon parents to act in conjunction with physicians as
agents in negotiating the health care delivery system. We examine
the effects of prescription drug cost-sharing on prescription drug
utilization for children and adults diagnosed with persistent
asthma. METHODS: A repeated cross-section design was used
to study the effects of prescription drug cost-sharing on asthma
drug utilization. Multivariate models were estimated to assess
the effects of cost-sharing on asthma drug use (any asthma drug
use, number of asthma prescriptions, and number of prescrip-
tions conditional on use). Standard errors were adjusted for clus-
tering by patient for patients appearing in more than one year.
The 2000 through 2003 MarketScan database was the data
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OBJECTIVES: Consumers expect pharmacists to dispense med-
ication accurately, efﬁciently, and conveniently. In this environ-
ment, opportunities exist to investigate how medication safety
may be compromised when cognitive processes interfere with
sociotechnical (interaction of the social and technological
systems) variables to cause dispensing errors as perceived by
pharmacists in community practice. METHODS: Attitudinal
items relating to the sociotechnical aspects of pharmacy design,
drive through window pick-up service, and automated dispens-
ing system use were evaluated using a ﬁve-point Likert-type scale
with respect to dispensing errors and communication, prescrip-
tion processing, prescription volume, and physical mobility in
the pharmacy. A response rate of 45% (n = 429) was obtained
from a two-page survey that was mailed to a geographically
stratiﬁed random sample of community pharmacies in the United
States. RESULTS: Pharmacists attributed 80.3% of the perceived
dispensing errors to cognition and 15.8% of the errors to phar-
macy design. Signiﬁcant differences (p < 0.05) were observed for
the sociotechnical variables related to pharmacy design, drive
through window pick-up service, and automated dispensing
system use. The perceived dispensing error rate averaged among
the three pharmacy settings (mass merchant, chain, and inde-
pendent pharmacies) was 0.057%, and the number of dispens-
ing errors was positively and signiﬁcantly (p < 0.001) correlated
with prescription volume. CONCLUSION: Perceptions of dis-
pensing errors by pharmacists are inﬂuenced by pharmacy
design, drive through pick-up window service, and automated
dispensing system use. From a policy perspective, greater effort
is needed to determine how cognitive processes relate to
sociotechnical variables in this environment, and how standards
for medication safety can be maintained and improved.
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OBJECTIVES: We investigated drug usage in Ankara and esti-
mated the cost of unsused medicines to social security agencies.
METHODS: A questionnaire was structured to ﬁnd out the drug
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source, representing the health care experience of enrollees in
employer-sponsored health plans in the U.S. The study popula-
tion consisted of 22,985 children 5 to 17 years old and 56,381
adults 18 to 54 years old, meeting the HEDIS criteria for per-
sistent asthma in 2001 or 2002. RESULTS: Higher copayments
for asthma prescription drugs did not affect the use of asthma
prescription drugs for children with asthma (any use, number of
prescriptions or number of prescriptions conditional on use (p >
0.10)). Conversely, adults with asthma were price-sensitive to
copayments for asthma drugs on all measures of use (p < 0.01).
These ﬁndings also held for children and adults who were diag-
nosed with asthma in both years. In addition, parents who 
children with asthma had tended to be less price-sensitive than
other adults. CONCLUSION: Commercially-insured parents 
in employer-sponsored health plans may be less sensitive to 
prescription drug prices, and may err on the side of caution by
providing medications to their children with asthma.
PHP4
FACTORS INFLUENCING USER CHOICES TO VISIT EITHER
GENERAL PRACTITIONERS OR COMMUNITY PHARMACISTS
FOR MINOR AILMENTS—A DISCRETE CHOICE EXPERIMENT
Hughes D1, Myles S2, Longo M2, Lisles C2, Hood K3
1University of Wales, Bangor, Bangor, UK, 2University of Glamorgan,
Pontypridd, UK, 3Cardiff University, Cardiff, UK
OBJECTIVES: To examine how patients, by use of a discrete
choice experiment, decide between visiting their general practi-
tioner or community pharmacist for the management of minor
ailments. METHODS: Focus groups were convened to identify
key attributes of interest and to explore feasible variation in these
attributes (levels). A postal DCE questionnaire was administered
to adult populations across Wales, UK. The attributes (levels)
chosen were: Location of consultation (GP surgery/pharmacy);
When seen (immediately/not immediately); Travel time (15
minutes/30 minutes); Length of consultation (5 minutes/10
minutes); Expenses (£2/£4). Each questionnaire included 17 
pairwise choices and 109 respondents generated 2006 usable
answers. A two-level logistic regression was performed to
analyse the data. RESULTS: Signiﬁcant beta coefﬁcients were
evident for all attributes other than location of consultation. The
largest increase in utility was with being seen immediately as
opposed to not immediately (Beta = 2.176; SE 0.174; p < 0.001).
A 10 minute consultation was preferred to a 5 minute consulta-
tion with GPs, however respondents preferred a quick consulta-
tion if they visited their community pharmacies. Being able to
save £2 and going to their GPs gave an increase in utility, regard-
less of whether they were seen by their GPs or pharmacists.
CONCLUSION: Everything else being equal, respondents pre-
ferred to see their GPs as their ﬁrst port of call, and to be seen
quickly with little travel time. There is potential to improve the
efﬁciency of policies aiming to increase the use of community
pharmacies in the management of minor ailments. This may be
accomplished by reinforcing the beneﬁts of the immediate and
local availability of community pharmacies that can offer brief
consultations, often at less or the same cost as consulting a
general practitioner to receive a prescription medicine.
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OBJECTIVES: Although the relationship between physician
waiting times and patient satisfaction has been examined, 
the inﬂuence of subsequent time spent with the physician on 
this relationship yet remains to be explored. This study examined
the relationship between patient waiting times, time spent with
the physician, and patient satisfaction ratings with primary care
physicians. METHODS: Cross-sectional survey data on a sample
of 5030 patients who rated their physicians on a web-based survey
developed to collect detailed information on patient experiences
with health care. The survey included self-reported information
on wait times, time spent with physician, and patient satisfaction.
RESULTS: Longer waiting times were associated with signiﬁ-
cantly lower patient satisfaction (p < 0.05); however, time spent
with the physician was the strongest correlate of satisfaction with
physician (partial rho = 0.51, p < 0.001). The decrement in sat-
isfaction associated with long waiting times is substantially
reduced with increased time spent with the physician (5 minutes
or more). Importantly, the combination of long waiting time to
see the physician and having a short physician visit is associated
with very low overall patient satisfaction. CONCLUSION: The
time spent with the physician is a stronger predictor of patient
satisfaction than the time spent in the waiting room. These results
suggest that shortening patient waiting times at the expense of
time spent with the patient to improve patient satisfaction scores
would be counter-productive.
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OBJECTIVES: Pharmaceutical samples are widely used for pro-
motion and marketing, yet little is known about who receives
samples or how their use is associated with patient’s out-of-pocket
prescription costs. We sought to examine the characteristics of
patients receiving samples and to describe the association between
sample receipt and prescription costs METHODS: We divided
the 2002–2003 Medical Expenditure Panel Survey, a nationally
representative, panel-design longitudinal study, into a baseline
period (the ﬁrst two interview rounds) and an analysis period (the
remaining three rounds). We conducted logistic and generalized
linear regression analysis of 5,881 individuals receiving no sample
during the baseline period. We deﬁned our main outcome mea-
sures as: (1) sample receipt, (2) out-of-pocket prescription expen-
ditures, and (3) total prescription expenditures. RESULTS: A total
of 781 (14%) individuals received at least one pharmaceutical
sample during the analysis period. On multivariate analyses
sample receipt was greater among those who were younger and
those not on Medicaid. In generalized linear regressions control-
ling for demographic characteristics and health care utilization,
the 180-day out-of-pocket prescription expenditures were $178
(standard error [SE] $3.9) for those never receiving samples.
Among those receiving samples, the corresponding out-of-pocket
prescription expenditures were $166 (SE $8.9) for periods before
sample receipt, $244 (SE $9.2) for periods during sample receipt,
and $212 (SE $12.4) for periods following sample receipt. Results
were similar when total prescription costs were examined. Analy-
ses stratiﬁed by baseline health care utilization and by sample use
for acute vs. chronic conditions suggested that “pent-up demand”
failed to explain the associations observed. CONCLUSION: Indi-
viduals receiving samples have higher prescription expenditures
than their counterparts. This ﬁnding suggests that sample recip-
ients remain disproportionately burdened by prescription costs
even after sample receipt.
